GGrantIndex
← Leaderboards

Titus Jonathon Boggon

Yale University

$12,450,065
Attributed
$22,461,259
Total exposure
15
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$22,461,259 · 15

By mechanism

R01$21,025,078 · 12
P50$964,385 · 1
S10$459,619 · 1
P41$12,177 · 1

Most similar at Yale University

Same institution · by research overlap

Others in their field

Top investigators on “Biochemical

Research focus

BiochemicalStructureSignal TransductionMolecularComplexPhosphotransferasesCellsProteinsRegulationMediatingBaseFamilyMutationSignal PathwayInsightProtein KinaseBinding (Molecular Function)GenesPathway InteractionsPhosphorylationDesignLaboratoriesBindingMalignant Neoplasms

Grant awards (67)

A Novel Mechanism of Ras Regulation Necessary for Normal Vascular Development$597,722
R01 · FY2025 · NS
Signaling mechanisms of the cerebral cavernous malformations protein complex$555,030
R01 · FY2025 · NS · contact PI
LIM domain kinases: regulation and substrate recognition$351,750
R01 · FY2025 · GM · contact PI
Signaling mechanisms of the cerebral cavernous malformations protein complex$555,030
R01 · FY2024 · NS · contact PI
Human Genetics and Molecular Mechanisms of Vein of Galen Aneurysmal Malformation$532,195
R01 · FY2024 · NS
LIM domain kinases: regulation and substrate recognition$351,750
R01 · FY2024 · GM · contact PI
LIM domain kinases: regulation and substrate recognition$33,926
R01 · FY2024 · GM · contact PI
Human Genetics and Molecular Mechanisms of Vein of Galen Aneurysmal Malformation$552,967
R01 · FY2023 · NS
P21-activated kinases in cell-cell and cell-matrix adhesion signaling$420,685
R01 · FY2023 · GM
LIM domain kinases: regulation and substrate recognition$351,750
R01 · FY2023 · GM · contact PI
LIM domain kinases: regulation and substrate recognition$93,610
R01 · FY2023 · GM · contact PI
Human genetics and molecular mechanisms of Vein of Galen aneurysmal malformation$553,785
R01 · FY2022 · NS
P21-activated kinases in cell-cell and cell-matrix adhesion signaling$420,685
R01 · FY2022 · GM
LIM domain kinases: regulation and substrate recognition$351,750
R01 · FY2022 · GM · contact PI
Human genetics and molecular mechanisms of Vein of Galen aneurysmal malformation$475,627
R01 · FY2021 · NS
P21-activated kinases in cell-cell and cell-matrix adhesion signaling$420,685
R01 · FY2021 · GM
Human genetics and molecular mechanisms of Vein of Galen aneurysmal malformation$475,039
R01 · FY2020 · NS
P21-activated kinases in cell-cell and cell-matrix adhesion signaling$420,685
R01 · FY2020 · GM
Specificity and regulation in a protein kinase cascade affecting the actin cytoskeleton$326,623
R01 · FY2020 · GM · contact PI
Specificity and regulation in a protein kinase cascade affecting the actin cytoskeleton$326,623
R01 · FY2019 · GM · contact PI
Specificity and regulation in a protein kinase cascade affecting the actin cytoskeleton$326,623
R01 · FY2018 · GM · contact PI
The function of MEKK3 interaction with CCM2$320,513
R01 · FY2018 · GM · contact PI
Specificity and regulation in a protein kinase cascade affecting the actin cytoskeleton$75,000
R01 · FY2018 · GM · contact PI
Molecular assembly and regulation of the cerebral cavernous malformation complex$364,219
R01 · FY2017 · NS · contact PI
Specificity and regulation in a protein kinase cascade affecting the actin cytoskeleton$326,623
R01 · FY2017 · GM · contact PI
The function of MEKK3 interaction with CCM2$320,513
R01 · FY2017 · GM · contact PI
Investigating cellular function and biochemical mechanism for STK24-CCM3 complex$316,350
R01 · FY2017 · GM
The RAC1 Pathway as aTarget for Melanoma Therapy$156,681
P50 · FY2017 · CA
Molecular assembly and regulation of the cerebral cavernous malformation complex$364,219
R01 · FY2016 · NS · contact PI
The function of MEKK3 interaction with CCM2$320,513
R01 · FY2016 · GM · contact PI
Investigating cellular function and biochemical mechanism for STK24-CCM3 complex$316,350
R01 · FY2016 · GM
The RAC1 Pathway as aTarget for Melanoma Therapy$156,828
P50 · FY2016 · CA
Molecular assembly and regulation of the cerebral cavernous malformation complex$364,219
R01 · FY2015 · NS · contact PI
The mechanism of Arg kinase activation by integrin B1$324,255
R01 · FY2015 · GM
The function of MEKK3 interaction with CCM2$320,513
R01 · FY2015 · GM
Investigating cellular function and biochemical mechanism for STK24-CCM3 complex$316,350
R01 · FY2015 · GM
Structure-directed investigations into the regulation of Ste20 kinases$316,350
R01 · FY2015 · GM · contact PI
The RAC1 Pathway as aTarget for Melanoma Therapy$158,496
P50 · FY2015 · CA
Upgrade of a home source macromolecular X-ray diffraction system.$459,619
S10 · FY2014 · OD · contact PI
Molecular assembly and regulation of the cerebral cavernous malformation complex$360,576
R01 · FY2014 · NS · contact PI
The mechanism of Arg kinase activation by integrin B1$324,267
R01 · FY2014 · GM
Structure-directed investigations into the regulation of Ste20 kinases$316,350
R01 · FY2014 · GM · contact PI
Investigating cellular function and biochemical mechanism for STK24-CCM3 complex$316,350
R01 · FY2014 · GM
The RAC1 Pathway as aTarget for Melanoma Therapy$155,903
P50 · FY2014 · CA
The mechanism of Arg kinase activation by integrin B1$22,449
R01 · FY2014 · GM
Regulation of polycystin-2 channel activity$379,492
R01 · FY2013 · DK · contact PI
Molecular assembly and regulation of the cerebral cavernous malformation complex$364,219
R01 · FY2013 · NS · contact PI
Structure-directed investigations into the regulation of Ste20 kinases$305,049
R01 · FY2013 · GM · contact PI
The mechanism of Arg kinase activation by integrin B1$303,792
R01 · FY2013 · GM
The RAC1 Pathway as aTarget for Melanoma Therapy$170,344
P50 · FY2013 · CA
Regulation of polycystin-2 channel activity$393,256
R01 · FY2012 · DK · contact PI
Structure and function of the integrin-linked kinase-PINCH-parvin complex$340,634
R01 · FY2012 · GM
The mechanism of Arg kinase activation by integrin B1$323,294
R01 · FY2012 · GM
Structure-directed investigations into the regulation of Ste20 kinases$315,400
R01 · FY2012 · GM · contact PI
The RAC1 Pathway as aTarget for Melanoma Therapy$166,133
P50 · FY2012 · CA
Structural basis of Jak3-mediated interleukin-2 family signal transduction$430,831
R01 · FY2011 · AI · contact PI
Regulation of polycystin-2 channel activity$393,256
R01 · FY2011 · DK · contact PI
Structure and function of the integrin-linked kinase-PINCH-parvin complex$340,634
R01 · FY2011 · GM
Regulation of polycystin-2 channel activity$479,952
R01 · FY2010 · DK · contact PI
Structural basis of Jak3-mediated interleukin-2 family signal transduction$443,161
R01 · FY2010 · AI · contact PI
Structure and function of the integrin-linked kinase-PINCH-parvin complex$344,075
R01 · FY2010 · GM
Structural basis of Jak3-mediated interleukin-2 family signal transduction$465,262
R01 · FY2009 · AI · contact PI
Structure and function of the integrin-linked kinase-PINCH-parvin complex$347,550
R01 · FY2009 · GM
Structural basis of Jak3-mediated interleukin-2 family signal transduction$405,786
R01 · FY2008 · AI · contact PI
Structural basis of Jak3-mediated interleukin-2 family signal transduction$42,916
R01 · FY2008 · AI · contact PI
STRUCTURAL STUDIES ON TYROSINE KINASES AND POLYCYSTIN-1 AND -2$12,177
P41 · FY2008 · RR · contact PI
Structural basis of Jak3-mediated interleukin-2 family signal transduction$406,000
R01 · FY2007 · AI · contact PI